Smith & Nephew plc (SNN)

Market Cap	12.14B
Revenue (ttm)	5.22B
Net Income (ttm)	223.00M
Shares Out	436.68M
EPS (ttm)	0.51
PE Ratio	54.58
Forward PE	16.50
Dividend	$0.38 (1.38%)
Ex-Dividend Date	Sep 29, 2022

Volume	547,788
Open	27.81
Previous Close	28.04
Day's Range	27.67 - 27.96
52-Week Range	21.78 - 34.12
Beta	0.35
Analysts	Buy
Price Target	33.22 (+19.45%)
Earnings Date	Feb 28, 2023

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform m...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 16, 1999
• Employees: 18,000
• Stock Exchange: NYSE
• Ticker Symbol: SNN

Financial Performance

In 2022, Smith & Nephew's revenue was $5.22 billion, an increase of 0.06% compared to the previous year's $5.21 billion. Earnings were $223.00 million, a decrease of -57.44%.

Analyst Forecast

According to 21 analysts, the average rating for SNN stock is "Buy." The 12-month stock price forecast is $33.22, which is an increase of 19.45% from the latest price.

Price Target

$33.22

(19.45% upside)

Analyst Consensus: Buy